New scan could reveal hidden heart damage in Protein-Buildup disease

NCT ID NCT07549841

Not yet recruiting Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Apr 29, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study tests a special PET scan that uses a tracer called [68Ga]Ga-FAPI-46 to see how active scarring is in the hearts of people with transthyretin cardiac amyloidosis, a disease where abnormal protein builds up and weakens the heart. About 40 adults with this condition will get the scan to see if it can better show how severe the disease is and which patients are getting worse despite treatment. The goal is to find a new way to guide personalized care, not to treat the disease itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN CARDIAC AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu Nantes

Nantes, 44093, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

TRANSTHYRETIN CARDIAC AMYLOIDOSIS